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Abstract
Background: Intracellular vesicle fusion is mediated by the interactions of SNARE (soluble N-ethylmaleimide-sensitive factor
attachment protein receptor) proteins on vesicles (v-SNAREs) and on target membranes (t-SNAREs). The vesicle-associated
membrane proteins (VAMPs) are v-SNAREs that reside in various post-Golgi vesicular compartments. To fully understand the
specific role of each VAMP in vesicle trafficking, it is important to determine if VAMPs have differential membrane fusion
activities.
Methodology/Principal Findings: In this study, we developed a cell fusion assay that quantifies SNARE-mediated
membrane fusion events by activated expression of b-galactosidase, and examined fusogenic pairings between the seven
VAMPs, i.e., VAMPs 1, 2, 3, 4, 5, 7 and 8, and two plasma membrane t-SNARE complexes, syntaxin1/SNAP-25 and syntaxin4/
SNAP-25. VAMPs 1, 2, 3, 4, 7 and 8 drove fusion efficiently, whereas VAMP5 was unable to mediate fusion with the t-SNAREs.
By expressing VAMPs 1, 3, 4, 7 and 8 at the same level, we further compared their membrane fusion activities. VAMPs 1 and
3 had comparable and the highest fusion activities, whereas VAMPs 4, 7 and 8 exhibited 30–50% lower fusion activities.
Moreover, we determined the dependence of cell fusion activity on VAMP1 expression level. Analysis of the dependence
data suggested that there was no cooperativity of VAMP proteins in the cell fusion reaction.
Conclusions/Significance: These data indicate that VAMPs have differential membrane fusion capacities, and imply that
with the exception of VAMP5, VAMPs are essentially redundant in mediating fusion with plasma membrane t-SNAREs.
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Introduction
Eucaryotic cells consist of membrane-bound organelles that have
distinct functions. Transport of proteins and lipids among organelles
relies on vesicles that are generated at donor organelles and then
delivered to target organelles. The final event of the vesicular delivery
process is the fusion of vesicles with the target organelles. SNARE
(soluble N-ethylmaleimide-sensitive factor attachment protein recep-
tor) proteins form the core machinery for vesicle fusion [1–3].
SNAREs belong to a superfamily of cytoplasmic oriented
transmembrane proteins with more than 35 members in humans
[4]. All SNAREs share a homologous sequence of 60–70 amino
acids, the ‘‘SNARE motif’’ that contains eight heptad repeats
ready for coiled-coil formation. When vesicles traffic to the vicinity
of the target organelles, SNARE proteins on vesicles (v-SNAREs)
and on target membranes (t-SNAREs) form trans-SNARE
complexes to draw the two membranes toward each other and
drive membrane fusion. Four a-helices contributed by the SNARE
motifs in v- and t-SNAREs intertwine to form an extremely stable
four-helix bundle that is characterized by 16 layers of mostly
hydrophobic interactions between amino acid side chains [5].
Assembly of trans-SNARE complexes starts from the N-termini
and proceeds to the C-termini in a zippering fashion [6]. Energy
made available from the assembly of trans-SNARE complexes is
used to drive the fusion of lipid bilayers [7–9]. After membrane
fusion, the SNARE complexes become cis-complexes in the target
membranes. The adapter protein SNAP (soluble NSF attachment
protein) and the ATPase NSF (N-ethylmaleimide-sensitive factor)
dissociate cis-SNARE complexes at the expense of ATP [10,11] to
free SNAREs for the next round of fusion.
The SNARE proteins that mediate synaptic exocytosis are
well-characterized. In synapses, the v-SNARE vesicle-associated
membrane protein 2 (VAMP2) is present in synaptic vesicles, while
t-SNAREs syntaxin1 and synaptosomal-associated protein of
25 kDa (SNAP-25) are located in the plasma membrane. Before
the assembly of trans-SNARE complexes, syntaxin1 and SNAP-25
constitute a t-SNARE acceptor complex for VAMP2 [12]. One a-
helix from VAMP2, one a-helix from syntaxin1 and two a-helices
from SNAP-25 form the four-helix bundle to drive the fusion of
synaptic vesicles with the plasma membrane [5].
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[13], suggesting that each SNARE has selective roles in vesicle
trafficking events. The 7 vesicle-associated membrane proteins
(VAMPs) reside in various post-Golgi vesicular compartments, and
mediate vesicle fusion with the plasma membrane, the trans-Golgi
network (TGN) and endosomes. In particular, VAMP1 (synapto-
brevin 1) and VAMP2 (synaptobrevin 2) mediate regulated
exocytosis in neurons and endocrine cells [14–16]. Enriched in
recycling endosomes and endosome-derived vesicles [17], VAMP3
(cellubrevin) has been implicated in the secretion of a-granules in
platelets [18,19], the recycling of transferrin receptors to the cell
surface [20], and vesicular trafficking of integrins [21,22]. Present
primarily in the TGN, VAMP4 participates in transport between
the TGN and endosomes [23,24] and in homotypic fusion of early
endosomes [25]. Preferentially expressed in muscle cells, VAMP5
(myobrevin) is associated with the plasma membrane and
intracellular vesicles [26]. In addition to apical exocytosis in
polarized epithelial cells [27,28], the tetanus neurotoxin-insensitive
VAMP (VAMP7) is involved in vesicular transport from
endosomes to lysosomes [29]. Preferentially associated with early
endosomes [30,31], VAMP8 (endobrevin) is required in regulated
exocytosis in pancreatic acinar cells [32].
VAMPs 3, 4, 7 and 8 have broad tissue distribution [17,30].
Originally identified in nervous tissues, VAMPs 1 and 2 are also
detected in skeletal muscle, fat and other tissues [33–37].
Therefore, in mammalian cells, multiple VAMPs are present to
mediate post-Golgi vesicle trafficking. To fully understand the
specific role of each VAMP in vesicular transport and fusion, it is
important to determine if VAMPs have differential membrane
fusion activities. An ideal experimental system to answer this
question will require a quantitative membrane fusion assay and
equal expression of VAMP proteins. In the current study, we
developed a cell fusion assay that quantifies SNARE-mediated
fusion events by activated expression of b-galactosidase, and used
immunostaining and flow cytometry to measure and titrate the
expression levels of VAMPs. By pairing VAMPs with 2 plasma
membrane t-SNARE complexes, syntaxin1/SNAP-25 [12] and
syntaxin4/SNAP-25 [38], we compared their membrane fusion
activities.
Results
An Enzymatic Cell Fusion Assay
In previous studies [9,39], we showed that ‘‘flipped’’ SNAREs
ectopically expressed at the cell surface drive cell-cell fusion,
demonstrating that SNAREs are sufficient to fuse cellular
membranes and providing a reconstituted system to study
SNARE-mediated membrane fusion. Nevertheless, because the
cell fusion assay is based on microscopic analysis, it becomes less
efficient when used to analyze multiple v-/t-SNARE combinations
quantitatively. To develop a more quantitative cell fusion assay,
we took advantage of the strong transcriptional activation by
binding of the tetracycline-controlled transactivator (tTA) to the
tetracycline-response element (TRE) [40]. To this end, two
plasmids in CLONTECH’s Tet-Off gene expression system were
used. The first plasmid pTet-Off encodes the transcriptional
activator tTA, and the second plasmid pBI-G encodes the LacZ
gene under control of the tetracycline-response element (TRE-
LacZ). In the absence of tTA, transcription of the LacZ gene in
TRE-LacZ is silent. When tTA is present, it binds to the TRE and
activates the transcription of LacZ, resulting in the expression of b-
galactosidase. We reasoned that if tTA was located in the cells that
expressed flipped v-SNARE proteins on the cell surface (v-cells)
and TRE-LacZ was located separately in the cells that expressed
flipped t-SNARE proteins on the cell surface (t-cells), b-
galactosidase would not be expressed. Fusion of the v- and t-
cells would result in the binding of tTA to TRE and the
transcriptional activation of LacZ (Fig. 1A). Since more cell fusion
events lead to the binding of more tTA molecules to TRE and thus
increased transcription of LacZ, the level of b-galactosidase
expression is expected to be proportional to the number of cell
fusion events.
To examine feasibility of the assay, we used the well-
characterized neuronal SNAREs (v-SNARE VAMP2, and t-
SNAREs syntaxin1 and SNAP-25), which drive cell fusion when
expressed on the cell surface [9]. VAMP2 was coexpressed with
tTA in v-cells, and syntaxin1 and SNAP-25 were coexpressed with
TRE-LacZ in t-cells. When the v- and t-cells were combined,
robust b-galactosidase expression was detected by a colorimetric
method within 24 h (Fig. 1B). However, when either VAMP2 was
not expressed in the v-cells or SNAP-25 was not expressed in the t-
cells, only small baseline b-galactosidase activity was detected
(Fig. 1B), indicating that cell fusion and expression of b-
galactosidase relied on interactions of the v- and t-SNAREs.
These experiments demonstrated that the enzymatic cell fusion
assay identifies fusogenic pairings between v- and t-SNAREs
efficiently. The baseline b-galactosidase expression was probably
caused by background transcription of TRE-LacZ in the absence
of tTA binding or by spreading of the reporter plasmids among the
v- and t-cells that did not involve cell fusion.
Fusogenic Pairings of VAMPs and plasma membrane t-
SNAREs
The enzymatic cell fusion assay was used to investigate if all 7
VAMPs form fusogenic pairings with the plasma membrane t-
SNAREs syntaxin1/SNAP-25 and syntaxin4/SNAP-25. The
flipped VAMP2, VAMP3, syntaxin1, syntaxin4 and SNAP-25
constructs have been reported [9,39]. Since the current focus is
membrane fusion capacity of v-/t-SNARE interactions but not
regulation of SNARE function, we used the syntaxin1 and
syntaxin4 constructs in which the inhibitory N-terminal domains
of syntaxins were removed. The truncated syntaxin proteins have
higher membrane fusion activities than the full-length proteins
[39,41].
To develop constructs of flipped VAMPs 1, 4, 5, 7 and 8, the
preprolactin signal sequence was fused to the N-termini of the
VAMPs, and a Myc tag was inserted between the signal sequence
and the N-termini (Fig. 2 A). Staining of transfected COS-7 cells
with an anti-Myc antibody showed that VAMPs 1, 3, 4, 5, 7 and 8
were expressed at the cell surface (Fig. 2B). The expression of
VAMPs 5 and 8 was visibly higher than VAMPs 1, 3, 4 and 7. Cell
surface expression of flipped VAMP2 protein, which does not
contain a Myc tag, has been described [9]. Because there are
putative N-glycosylation motifs (Asn-X-Ser/Thr) in VAMPs 1, 4,
5, 7 and 8, tunicamycin (6.7 mg/ml) was included in cell culture
medium to prevent N-glycosylation of these VAMP proteins.
Likewise, when COS-7 cells were cotransfected with flipped
syntaxin1 and SNAP-25, both t-SNARE proteins were expressed
at the cell surface (Fig. 2C). When cells were cotransfected with the
same amount of flipped syntaxin4 and SNAP-25, more syntaxin4/
SNAP-25 proteins were detected at the cell surface than
syntaxin1/SNAP-25 proteins (compare top and bottom rows in
Fig. 2C). As shown previously [9,39], SNAP-25, which does not
contain a transmembrane domain, was anchored to the cell
surface by forming complexes with syntaxins.
Using the enzymatic fusion assay (Fig. 1), we examined the
fusogenic pairings between the VAMPs and t-SNAREs. Robust b-
galactosidase expression was detected when the v-cells expressing
Fusion Activities of VAMPs
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syntaxin1/SNAP-25 (Fig. 3A) or syntaxin4/SNAP-25 (Fig. 3B),
indicating that these VAMPs mediated membrane fusion with
plasma membrane t-SNAREs. With syntaxin1/SNAP-25, the 6
VAMPs drove fusion to a similar degree. With syntaxin4/SNAP-
25, VAMP8 fused less efficiently than VAMPs 1, 2, 3 and 4 (31%
lower fusion activity and P=0.046 vs. VAMP1, Fig. 3B). In
contrast, when the v-cells expressing VAMP5 were combined with
the t-cells, we detected only baseline b-galactosidase activity,
which was comparable to the b-galactosidase activity produced by
the control cells that did not express v-SNAREs (Figs. 3A and B),
suggesting that VAMP5 did not drive membrane fusion with
syntaxin1/SNAP-25 or syntaxin4/SNAP-25. The stronger fusion
activities of syntaxin4/SNAP-25 than syntaxin1/SNAP-25 (com-
pare Figs. 3A and B) can be explained by higher cell surface
expression of syntaxin4/SNAP-25 (Fig. 2C) and higher fusion
activity of syntaxin4 than syntaxin1 (see Fig. 5 below). Taken
together, the data shown in Fig. 3 indicated that VAMPs 1, 2, 3, 4,
7 and 8, but not VAMP5, drove membrane fusion when
partnering with plasma membrane t-SNAREs.
Comparison of membrane fusion activities of VAMPs
In order to compare the membrane fusion capacities of VAMPs,
the v-SNAREs need to be expressed at the same level. Since
flipped VAMPs 1, 3, 4, 5, 7 and 8, and syntaxins 1 and 4 contain a
Myc tag, we measured cell surface expression of the SNARE
proteins by anti-Myc staining and flow cytometry (Fig. 4A). When
COS-7 cells were transfected with the flipped SNARE plasmids at
the same concentration, cell surface expression of VAMPs 5 and 8
was more than 2 fold higher than VAMPs 1, 3, 4 and 7, and cell
surface expression of syntaxin4 was 1.8 fold higher than syntaxin1
(Fig. S1). To express the v- and t-SNAREs at the same level, we
titrated and optimized the concentration of each flipped SNARE
plasmid used in transfection. Under such conditions, VAMPs 1, 3,
4, 5, 7 and 8 were expressed at same level at the cell surface, while
syntaxins 1 and 4 were expressed at the same level (Fig. 4B).
Because the flipped VAMP2 protein does not contain a Myc tag
[9], we were not able to compare its expression with the other
VAMPs.
After expressing VAMPs 1, 3, 4, 5, 7 and 8 at the same level, we
compared their membrane fusion activities using the enzymatic
Figure 1. Enzymatic cell fusion assay. (A) In COS-7 cells that expressed v-SNARE proteins on the surface (v-cells), flipped v-SNARE was
cotransfected with a plasmid that encodes the tetracycline-controlled transactivator (tTA). In COS-7 cells that expressed t-SNARE proteins on the
surface (t-cells), flipped t-SNAREs were cotransfected with a reporter plasmid that encodes b-galactosidase under control of the tetracycline-response
element (TRE-LacZ). 24 h after transfection, v-cells were detached from cell culture dishes, and then overlaid on t-cells. Fusion of the v- and t-cells led
to the binding of tTA to TRE and expression of b-galactosidase. (B) Cell fusion depends on the interactions of v- and t-SNAREs. v-cells that expressed
tTA and VAMP2 were incubated with t-cells that expressed TRE-LacZ, syntaxin1 and SNAP-25. After 24 h, the cells were lysed and the activity of b-
galactosidase in the lysates was determined using a colorimetric method by absorbance at 420 nm. Only baseline b-galactosidase activity was
detected when either flipped VAMP2 or SNAP-25 was omitted from transfection. Error bars represent standard deviation of four independent
experiments.
doi:10.1371/journal.pone.0014238.g001
Fusion Activities of VAMPs
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had comparable and the highest fusion activities, whereas VAMPs
4 and 7 had 50% and 30% lower fusion activities, respectively
(Figs. 5A and B). With syntaxin4/SNAP-25, VAMPs 1 and 3 had
comparable and the highest fusion activities, whereas VAMPs 4, 7
and 8 had 36%, 26% and 54% lower fusion activities, respectively
(Figs. 5C and D). As expected, only baseline b-galactosidase
activity was detected when VAMP5 was paired with the t-
SNAREs. These data indicated that VAMPs have differential
membrane fusion activities with plasma membrane t-SNAREs.
When expressed at the same level, syntaxin4 drove fusion more
efficiently than syntaxin1 (compare Figs. 5A and C), suggesting
that syntaxin4 has higher membrane fusion activity than
syntaxin1.
Having shown that VAMPs have differential fusion activities,
we sought to determine if membrane fusion by VAMPs follows
different time courses. Cell fusion by VAMPs 1, 3, 4, 5, 7 or 8 and
syntaxin1/SNAP-25 was measured at 6, 12 or 24 h after
combining the v- and t-cells. The results in Fig. 5E showed that
cell fusion by VAMPs 1, 3, 4, 7 and 8 followed similar time
courses, with peak b-galactosidase activity detected at 12 h. The
slight drop of b-galactosidase activities at 24 h was likely caused by
detachment of some of the fused cells from cell culture plates.
To rule out the possibility that the baseline b-galactosidase
activity detected in the VAMP5 combinations (Fig. 5) was caused
by residual fusion activity of VAMP5, we performed the
microscopic cell fusion assay [39], which analyzes individual cell
fusion events and can detect rare fusion events. In this assay,
flipped v-SNAREs are coexpressed with the green fluorescent
protein EGFP in v-cells and flipped t-SNAREs are coexpressed
with the red fluorescent protein DsRed2 in t-cells. Fusion of the v-
and t-cells results in fused cells whose cytoplasm is yellow under
fluorescence microscope (Fig. 6). As predicted by the enzymatic
cell fusion results, VAMP4 drove cell fusion with syntaxin1/
SNAP-25 and syntaxin4/SNAP-25 in the microscopic assay
(Fig. 6). In multiple experiments, no cell fusion was observed
using the microscopic assay when v-cells expressing VAMP5 were
combined with t-cells expressing syntaxin1/SNAP-25 or syn-
taxin4/SNAP-25 (Fig. 6). Based on the results using both the
enzymatic and microscopic cell fusion assays, we concluded that
VAMP5 is unable to mediate membrane fusion with the plasma
membrane t-SNAREs.
Dependence of cell fusion activity on cell surface density
of VAMP1
We next asked how many SNARE complexes cooperate to
drive the cell fusion reaction. To this end, we determined the
dependence of cell fusion activity on cell surface expression level of
VAMP1, which has high fusion activity (Fig. 5). COS-7 cells were
transfected with increasing concentrations of the flipped VAMP1
plasmid. At each concentration, we measured the cell surface
expression level of VAMP1 proteins using immunostaining and
flow cytometry, and determined cell fusion activity of VAMP1
with syntaxin1/SNAP-25 using the enzymatic fusion assay. Cell
fusion activity was then plotted as a function of the mean
fluorescence intensity of VAMP1 staining (Fig. 7A). The
correlation was best fit with a polynomial regression. The
hyperbolic instead of sigmoidal correlation (Fig. 7A) suggests that
there was no cooperativity of VAMP1 proteins in driving cell
fusion.
The log-log plot was used to determine the cooperativity of the
viral fusion protein hemagglutinin in membrane fusion [42]. Using
log-log plot, we further analyze the cooperativity of VAMP1
proteins. If three VAMP1 (V) proteins are required in the cell
Figure 2. Expression of flipped SNARE proteins at the cell
surface. (A) Domain structure of flipped VAMPs. The preprolactin
signal sequence (SS) was fused to the N-termini of VAMPs 1, 3, 4, 5, 7
and 8. A Myc tag was inserted between the signal sequence and the
VAMP proteins. (B) COS-7 cells were cotransfected with tTA and the
empty vector pcDNA3.1(+), flipped VAMPs 1, 3, 4, 5, 7 or 8. 24 h after
transfection, unpermeabilized cells were stained with an anti-Myc
monoclonal antibody to detect the expression of VAMPs at the cell
surface. (C) COS-7 cells were cotransfected with TRE-LacZ, flipped SNAP-
25 and syntaxins 1 or 4. 24 h after transfection, unpermeabilized cells
were dual labeled with antibodies. Syntaxins 1 and 4 were labeled with
the anti-Myc monoclonal antibody (green), and SNAP-25 was labeled
with a polyclonal antibody (red). Representative confocal microscopy
images of four independent experiments are shown. Scale bar, 20 mm.
doi:10.1371/journal.pone.0014238.g002
Fusion Activities of VAMPs
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[V]
3. Therefore, log (F) =log (k) +3 log [V], and the slope of the
resulting log-log plot will be 3. A log-log analysis of the
dependence of cell fusion activity on VAMP1 cell surface density
is shown in Fig. 7B. In this analysis, F= fusion activity (OD420)
and [V] = mean fluorescence intensity of VAMP1 staining.
Linear regression was performed to model the log-log correlation
(Fig. 7B), and the resulting slope was 0.52. When only the 3 data
points with the lowest VAMP1 expression were modeled by linear
regression, the slope was 0.62. These analyses further suggest that
the cell fusion reaction did not involve concerted action of
VAMP1 proteins.
Discussion
In this study, we have developed a cell fusion assay that
quantifies SNARE-mediated fusion events by activated expression
of b-galactosidase. Using this assay, we showed that VAMPs 1, 2,
3, 4, 7 and 8 mediated fusion efficiently with syntaxin1/SNAP-25
and syntaxin4/SNAP-25, whereas VAMP5 did not drive fusion
Figure 3. Cell fusion by VAMPs and plasma membrane t-SNAREs. 24 h after transfection, v-cells that expressed tTA and VAMPs 1, 2, 3, 4, 5, 7
or 8 were combined with t-cells that expressed TRE-LacZ and (A) syntaxin1/SNAP-25 or (B) syntaxin4/SNAP-25. After 24 h, cell fusion was quantified
using the enzymatic cell fusion assay. Control cells (-VAMP) were cotransfected with the empty vector and the plasmid encoding tTA. Only baseline b-
galactosidase activity was detected when the control cells were incubated with the t-cells. The flipped SNARE plasmids were transfected at the same
concentration. Error bars represent standard deviation of three independent experiments. * P,0.05 vs. VAMP1.
doi:10.1371/journal.pone.0014238.g003
Fusion Activities of VAMPs
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a measurement of cell surface SNARE expression, we expressed
VAMPs 1, 3, 4, 7 and 8 at the same level and further compared
their membrane fusion activities. With syntaxin1/SNAP-25,
VAMPs 1, 3 and 8 had comparable and the highest fusion
activities, while VAMPs 4 and 7 had 50% and 30% lower fusion
activities, respectively. With syntaxin4/SNAP-25, VAMPs 1 and 3
had comparable and the highest fusion activities, while VAMPs 4,
7 and 8 had 36%, 26% and 54% lower fusion activities,
respectively. Taken together, these data indicate that VAMPs
have differential membrane fusion activities. However, when
expressed at higher levels, VAMP4 drove membrane fusion as
efficiently as VAMPs 1 and 3 (Fig. 3). In addition, the differences
of fusion activities among the fusogenic VAMPs are within a factor
of 2, implying that with the exception of VAMP5, VAMPs are
essentially redundant in mediating membrane fusion with plasma
membrane t-SNAREs.
VAMPs 1, 2, 3, 7 and 8 are known to mediate vesicle fusion
with the plasma membrane. The current study provides additional
evidence that vesicles that carry either one of these 5 VAMPs are
Figure 4. FACS analysis of SNARE expression at the cell surface. 24 h after cotransfection with tTA and the empty vector, flipped VAMPs 1, 3,
4, 5, 7 or 8 (v-cells), or 24 h after cotransfection with TRE-LacZ, flipped SNAP-25 and syntaxins 1 or 4 (t-cells), unpermeabilized COS-7 cells were
stained with an anti-Myc antibody, and then analyzed by flow cytometry. (A) Representative FACS profiles of the cells transfected with the empty
vector, flipped VAMP1 or syntaxin4/SNAP-25. (B) To express the v- and t-SNAREs at same level at the cell surface, flipped SNARE plasmids were
transfected at the following concentrations (per 10 cm
2 growth area, i.e., per well in 6-well plates): VAMP1, 0.2 mg; VAMP3, 0.5 mg; VAMP4, 0.5 mg;
VAMP5, 0.05 mg; VAMP7, 1.0 mg; VAMP8, 0.1 mg; syntaxin1, 0.5 mg; syntaxin4, 0.05 mg. tTA, TRE-LacZ and flipped SNAP-25 were cotransfected at 1 mg
per 10 cm
2 growth area. The mean fluorescence intensity of staining of the SNAREs was determined by FACS analysis. Error bars represent standard
deviation of four independent experiments.
doi:10.1371/journal.pone.0014238.g004
Fusion Activities of VAMPs
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are functionally redundant, they can compensate each other in loss
of function studies [43]. VAMP4 mainly localizes to the TGN
[23,44], with a small percentage (,6%) of VAMP4 proteins
present in endosomal vesicles [23]. Forming a v-/t-SNARE
complex with syntaxin16, syntaxin6 and vti1a, VAMP4 is involved
Figure 5. Comparison of fusion activities of VAMPs. To express VAMPs 1, 3, 4, 5, 7 and 8 at same level at the cell surface, and to express
syntaxin1/SNAP-25 and syntaxin4/SNAP-25 at the same level, plasmids were transfected at the concentrations described in the legend of Fig. 4B. (A
and C) 24 h after mixing the v- and t-cells, cell fusion was quantified using the enzymatic fusion assay. Error bars represent standard deviation of four
independent experiments. **P,0.01 vs. VAMP1; *** P,0.001 vs. VAMP1. (B and D) The fusion activities (OD420) of the control cells expressing the
empty vector (-VAMP) and the v-cells expressing VAMPs 3, 4, 5, 7 or 8 were normalized to the fusion activity of the v-cells expressing VAMP1. Error
bars represent standard deviation of the four independent experiments. (E) Time course of cell fusion. 6, 12 or 24 h after combining the v-cells
expressing different VAMPs with the t-cells expressing syntaxin1/SNAP-25, cell fusion was quantified. The time-course curve of the VAMP5-expressing
cells overlapped completely with the time-course curve of the control cells. Shown is a representative of two independent experiments.
doi:10.1371/journal.pone.0014238.g005
Fusion Activities of VAMPs
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with syntaxin13, syntaxin6 and vti1a, VAMP4 mediates homo-
typic fusion of early endosomes [25]. The current data show that
VAMP4 drives membrane fusion with plasma membrane t-
SNAREs, suggesting that VAMP4 may mediate a third vesicle
fusion event - fusion of vesicles with the plasma membrane.
VAMP5 is preferentially expressed in the skeletal muscle and
heart and its expression increases during myogenesis [26]. In
muscle cells, VAMP5 is mainly associated with the plasma
membrane as well as intracellular vesicles [26,45]. Our data show
that VAMP5 is unable to mediate membrane fusion with plasma
membrane t-SNAREs, suggesting that VAMP5 does not mediate
Figure 6. VAMP5 does not mediate membrane fusion with plasma membrane t-SNAREs. v-cells expressing VAMPs 4 or 5 were labeled by
the green fluorescent protein EGFP. t-cells expressing syntaxin1/SNAP-25, syntaxin4/SNAP-25, syntaxin1 alone, or syntaxin4 alone were labeled by the
red fluorescent protein DsRed2. The v- and t-cells were combined for 24 h. EGFP and DeRed2 were imaged sequentially on a confocal microscope
before merging the images. Representative confocal images of three independent experiments are shown. Arrows indicate fused cells with a yellow
cytoplasm. Scale bar, 100 mm.
doi:10.1371/journal.pone.0014238.g006
Fusion Activities of VAMPs
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VAMP5 as a v-SNARE warrants further investigation.
Many kinds of secretory molecules and transmembrane proteins
are delivered to the cell surface by exocytosis. If VAMPs are
functionally redundant, what roles do SNAREs play in achieving
specificity of vesicle fusion at the plasma membrane? First, VAMPs
have distinct subcellular localizations (for example, VAMP8 is
mainly associated with early endosomes, whereas VAMP3 is
enriched in recycling endosomes). Specific VAMP thus mediates
the fusion of different populations of vesicles with the plasma
membrane. Second, syntaxins are present in distinct domains at
the plasma membrane. In polarized epithelial cells, syntaxin4 is
restricted to the basolateral domain of plasma membrane [46],
whereas syntaxin1 is delivered to both the apical and basolateral
domains [47]. Therefore, VAMPs may partner with syntaxin4 to
deliver cargo molecules to the basolateral side of the plasma
membrane, and partner with syntaxin1 to deliver cargo molecules
to both the apical and basolateral sides. Furthermore, specificity of
vesicle fusion is enhanced by the binding of regulatory proteins
such as Munc18 to SNAREs [48].
The number of SNARE complexes that cooperate to mediate
vesicle fusion is under active investigation. Using various model
Figure 7. Dependence of cell fusion activity on cell surface density of VAMP1. (A) v-cells were cotransfected with tTA (1 mg per 10 cm
2
growth area) and increasing amount of the flipped VAMP1 plasmid (per 10 cm
2 growth area): 0.01, 0.02, 0.05, 0.1, 0.2 and 0.5 mg. After the v-cells
were combined with the t-cells expressing syntaxin1/SNAP-25 for 24 h, cell fusion was quantified. In parallel experiments, the expression level of
VAMP1 proteins at surface of the v-cells was determined by staining with the anti-Myc antibody and FACS analysis. A polynomial regression curve
was generated to model the relationship between cell fusion activity (OD420) and mean fluorescence intensity of VAMP1 staining. Error bars represent
standard deviation of three independent experiments. (B) Log-log plot of cell fusion activity vs. mean fluorescence intensity of VAMP1 staining. The
solid line shows a linear regression, which yields a slope of 0.52 with a correlation coefficient of 0.901.
doi:10.1371/journal.pone.0014238.g007
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fusion assays, 1 to 11 SNARE complexes are estimated to be
needed for membrane fusion [49–52]. In intact neuroendocrine
cells, the fast phase of exocytosis requires at least 3 SNARE
complexes, while the slower phase of exocytosis may occur with 1
SNARE complex [53]. In this study, we determined the
dependence of cell fusion activity on cell surface density of
VAMP1, and did not observe cooperativity of VAMP1 proteins in
the cell fusion reaction. These data suggest that concerted action of
multiple SNARE complexes is not required to fuse cellular
membranes. However, to achieve fast exocytosis in intact cells,
concerted action of multiple SNARE complexes is clearly needed.
Such cooperativity of SNARE complexes may be organized by the
binding of regulatory proteins such as Munc18 and synaptotag-
mins.
The original cell fusion assay [9] analyzes SNARE-mediated
fusion events by fluorescence microscopy. The enzymatic cell
fusion assay described here utilizes controlled expression of b-
galactosidase and spectrometric measurement, and thus dramat-
ically simplify the quantification of fusion events. In addition, flow
cytometry is now used to measure the levels of SNARE expression.
With these modifications, the cell fusion assay offers a quantitative
approach for examining the fusogenic pairings of v- and t-
SNAREs and for high-throughput studies.
Materials and Methods
Cell culture and reagents
COS-7 cells were obtained from the American Type Culture
Collection, and cultured in Dulbecco Modified Eagle’s Medium
(DMEM) supplemented with 4.5 g/l glucose and 10% fetal bovine
serum (FBS). The anti-Myc monoclonal antibody 9E10, developed
by Dr. Bishop, was obtained from the Developmental Studies
Hybridoma Bank maintained by the University of Iowa.
Constructs of Flipped VAMPs
To generate flipped VAMP1, the flipped syntaxin1 plasmid
(pCH9) [9] was digested with XbaI and ApaI to excise the coding
region of syntaxin1. The vector fragment was purified from an
agarose gel. The coding sequence of mouse VAMP1 was amplified
by PCR from a mouse skeletal muscle Marathon-Ready cDNA
library (CLONTECH) with primers VP1F (TCTGTCTA-
GATCTGCTCCAGCTCAACCGC) and VP1R (AAACGGG-
CCCTCAAGTAAAAAAGTAGATTACAATCACTACCACG).
Using the PCR product as template, the coding sequence of
VAMP1 (a.a. 2–118) was further amplified by PCR with primers
CHU7F (TCTGTCTAGATCTGCTCCAGCTCAACCG) and
CHU7R (TAAACGGGCCCTCAAGTAAAAAAGTAGATTA-
CAATCACTACCAC). The new PCR product was digested with
XbaI and ApaI and cloned into the XbaI and ApaI sites of pCH9,
resulting in plasmid flipped VAMP1 (pCHU7).
To generate flipped VAMP4, the coding sequence of human
VAMP4 (a.a. 1–141) was amplified by RT-PCR using total RNA
isolated from human umbilical cord endothelial (HUVEC) cells
with primers XbaVMP4 (CTGTCTAGAATGCCTCCCAA-
GTTTAAGCGCCACC) and VMP4Apa (AAACGGGCCCT-
CAAGTACGGTATTTCATGACTATAAG). The PCR product
was digested with XbaI and ApaI and cloned into the XbaI and
ApaI sites of pCH9, resulting in plasmid flipped VAMP4
(pCHL22).
To generate flipped VAMP5, the coding sequence of human
VAMP5 was amplified by RT-PCR using the total RNA isolated
from HUVEC cells with primers hVAMP5F (GCAGGAATA-
GAGTTGGAGCGGTG) and hVAMP5R (TCAGTTCCCAG-
GCCCTGAGG). Using the PCR product as template, the coding
sequence of VAMP5 (a.a. 2–116) was further amplified by PCR
with primers CHL20F (TCTGTCTAGAGCAGGAATAGAG-
TTGGAGCGG) and CHL20R (AAACGGGCCCTCAGTTCC-
CAGGCCCTGAG). The new PCR product was digested with
XbaI and ApaI and cloned into the XbaI and ApaI sites of pCH9,
resulting in plasmid flipped VAMP5 (pCHL20).
To generate flipped VAMP7, the coding sequence of mouse
VAMP7 was amplified by PCR from the skeletal muscle Marathon-
Ready cDNA library with primers mVAMP7F (ATGGCCA-
TTCTTTTTGCTGTTGTTG) and mVAMP7R (TTATTT-
CTTCACACAGTTTGGCCATG). Using the PCR product as
template, the coding sequence of VAMP7 (a.a. 2–220) was further
amplified by PCR with primers CHU31F (TCTGTCTAGAGC-
CATTCTTTTTGCTGTTGTTGC) and CHU31R (AAACGG-
GCCCTTATTTCTTCACACAGTTTGGCCATG). The new
PCR product was digested with XbaI and ApaI and cloned into
the XbaI and ApaI sites of pCH9, resulting in plasmid flipped
VAMP7 (pCHU31).
To generate flipped VAMP8, the coding sequence of mouse
VAMP8 was amplified by PCR from the skeletal muscle
Marathon-Ready cDNA library with primers mVAMP8F (ATG-
GAGGAGGCCAGTGGGAG) and mVAMP8R (TTAAGTG-
GGGATGGTACCAGTGGC). Using the PCR product as
template, the coding sequence of VAMP8 (a.a. 2–101) was further
amplified by PCR with primers CHU32F (TCTGTCTAGA-
GAGGAGGCCAGTGGGAGTG) and CHU32R (AAACGGG-
CCCTTAAGTGGGGATGGTACCAGTGG). The new PCR
product was digested with XbaI and ApaI and cloned into the
XbaI and ApaI sites of pCH9, resulting in plasmid flipped
VAMP8 (pCHU32).
Pfu DNA polymerase (Stratagene) was used for PCR cloning.
SuperScript III reverse transcriptase (Invitrogen) was used for
reverse transcription. All coding sequences were confirmed by
DNA sequencing.
Immunostaining of SNAREs at the cell surface
The day before transfection, 3610
4 COS-7 cells were seeded on
sterile 12-mm glass coverslips contained in 24-well plates. In the
cells that expressed flipped v-SNARE proteins (v-cells), 0.25 mgo f
the plasmid that encodes tTA (pTet-Off, CLONTECH) was
cotransfected with 0.25 mg of the flipped VAMP constructs in each
well. In the cells that expressed flipped t-SNARE proteins (t-cells),
0.25 mg of the plasmid encoding TRE-LacZ (pBI-G, CLON-
TECH) was cotransfected with 0.25 mg each of flipped SNAP-25
and syntaxins 1 or 4 in each well. Transfection was done with
Lipofectamine according to the manufacturer’s instructions
(Invitrogen). 24 h after transfection, the COS-7 cells were fixed
with 4% paraformaldehyde in PBS++ (PBS supplemented with
0.1 g/l CaCl2 and 0.1 g/l MgCl2). Primary antibodies were
incubated with the cells at the following dilutions: anti-Myc
monoclonal antibody 9E10, neat hybridoma culture supernatant;
and anti-SNAP-25 polyclonal antibody (Synaptic Systems), 1:100.
Fluorophore-conjugated secondary antibodies (Jackson Immunor-
esearch Laboratories) were used at a dilution of 1:500. For double
staining, the cells were incubated first with a mixture of the
primary antibodies, and then with a mixture of the secondary
antibodies. Confocal images were collected on an Olympus laser
scanning confocal microscope. The images were processed with
the Adobe Photoshop software.
FACS analysis
The expression levels of SNAREs at the cell surface were
measured using immunostaining and flow cytometry as described
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5 COS-7 cells were seeded
in each well of 6-well plates (10 cm
2 growth area per well). 24 h
after transfection with the flipped SNARE, pTet-Off and pBI-G
plasmids, the cells were fixed with 1% paraformaldehyde in
PBS++ for 15 min, and then blocked in 10% FBS in PBS++ for
15 min. The cells were incubated with the anti-Myc monoclonal
antibody 9E10 for 60 min at room temperature. After three
washes with PBS++, the cells were labeled with FITC-conjugated
secondary antibodies (1:200 dilution) for 45 min. After three
washes with PBS++, the cells were scraped off the plates with a cell
scraper. 15,000 cells were analyzed using a FACSCalibur flow
cytometer (BD Biosciences) in the James Graham Brown Cancer
Center. The mean fluorescence intensity of each sample was
obtained using the CellQuest Pro software.
Enzymatic Cell Fusion Assay
The day before transfection, 1.2610
6 COS-7 cells were seeded
in each 100-mm tissue culture dish, and 2610
5 COS-7 cells were
seeded in each well of 6-well plates. For v-cells, 5 mg each of
flipped VAMPs 1, 2, 3, 4, 5, 7 or 8 was cotransfected with 5 mgo f
pTet-Off into the cells in each 100-mm culture dish. Control cells
were cotransfected with empty pcDNA3.1(+) vector and pTet-Off.
To prevent N-glycosylation of VAMPs 1, 4, 5, 7 and 8, v-cells
expressing these VAMP proteins and control cells were incubated
in cell culture medium containing 10 mg/ml of tunicamycin during
transfection. Since flipped VAMP2 [9] and VAMP3 proteins [39]
do not contain N-glycosylation motifs, v-cells expressing VAMPs 2
or 3 were not treated with tunicamycin. For t-cells, 1 mg each of
flipped syntaxins 1 or 4, SNAP-25 and pBI-G were cotransfected
into the cells in each well of the 6-well plates.
24 h after transfection, the v-cells were detached from the
culture dishes with EDTA (Enzyme-free Cell Dissociation Buffer
(Invitrogen)). The detached cells were counted with a hemacy-
tometer and resuspended in HEPES-buffered DMEM supple-
mented with 10% FBS, 6.7 mg/ml tunicamycin and 0.67 mM
DTT. Resuspended v-cells (4.8610
5) were added to each well
already containing the t-cells. After 6, 12 or 24 h at 37uCi n5 %
CO2, the expression of b-galactosidase was measured using the b-
Galactosidase Enzyme Assay System with Reporter Lysis Buffer
according to the manufacturer’s instructions (Promega). The cells
were washed twice with PBS, and then lysed in the Reporter Lysis
Buffer. Cell lysates were mixed with equal volume of Assay 26
Buffer, and the Reporter Lysis Buffer was mixed with the Assay
26 Buffer as a blank control. After 90 min, the colorimetric
reaction was stopped by adding 1 M sodium carbonate.
Absorbance at 420 nm was measured using a HITACHI 100-40
spectrophotometer.
To express VAMPs 1, 3, 4, 5, 7 and 8 at same level at the cell
surface to compare their membrane fusion activities, the flipped
VAMP and t-SNARE plasmids were transfected at different DNA
concentrations, which are described in the legend of Fig. 4B. To
determine the dependence of cell fusion activity on cell surface
density of VAMP1, v-cells were cotransfected with 5 mg of pTet-
Off and increasing amount of the flipped VAMP1 plasmid (see the
legend of Fig. 7A). Polynomial regression, linear regression and
log-log plot of the correlation data were performed using Microsoft
Excel.
Microscopic cell fusion assay
The microscopic cell fusion assay was performed as described
[39]. The day before transfection, 1.2610
6 COS-7 cells were
seeded in 100-mm tissue culture dishes, and 5610
4 COS-7 cells
were seeded on sterile 12-mm glass coverslips contained in 24-well
plates. To express VAMPs 4 and 5 at same level at the surface of v-
cells, 2.5 mg of flipped VAMP4 or 0.25 mg of flipped VAMP5 was
cotransfected with 5 mg of pEGFP-N3 into the cells grown in the
100-mm culture dishes. To express syntaxins 1 and 4 at same level
at the surface of t-cells, 0.125 mg of flipped syntaxin 1 or 0.0125 mg
of flipped syntaxin 4 was cotransfected with 0.25 mg each of
flipped SNAP-25 and pDsRed2-N1 into the cells seeded in the 24-
well plates. 24 h after transfection, the v-cells were detached and
combined with the t-cells. After 24 h at 37uCi n5 %C O 2, the
coverslips were gently washed once with PBS++, then fixed with
4% paraformaldehyde. Confocal images were collected on an
Olympus laser scanning confocal microscope. The 488 nm argon
laser line was used to excite the green fluorescent protein EGFP
and the 543 nm HeNe laser line was used to excite the red
fluorescent protein DsRed2. To prevent cross-contamination
between EGFP and DsRed2, each channel was imaged sequen-
tially before merging the images. Before cell fusion, the cytoplasm
of v-cells showed green fluorescence whereas the cytoplasm of t-
cells showed red fluorescence. Fusion of v- and t-cells resulted in
fused cells whose cytoplasm was yellow in the merged channel.
Supporting Information
Figure S1 FACS analysis of expression levels of SNAREs at the
cell surface. 24 h after cotransfection with tTA and the empty
vector, flipped VAMPs 1, 3, 4, 5, 7 or 8 (v-cells), or 24 h after
cotransfection with TRE-LacZ, flipped SNAP-25 and syntaxins 1
or 4 (t-cells), unpermeabilized COS-7 cells were stained with an
anti-Myc antibody, and then analyzed by flow cytometry. The
mean fluorescence intensity of staining of the SNAREs was
determined by FACS analysis. Each plasmid was transfected at
1 mg per 10 cm2 growth area. Error bars represent standard
deviation of two independent experiments.
Found at: doi:10.1371/journal.pone.0014238.s001 (0.01 MB
PDF)
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